News
November 5, 2007 - A pooled analysis of the E-SIRIUS and C-SIRIUS trials, called New SIRIUS, found that the CYPHER sirolimus-eluting coronary stent continued to provide clinical benefits with similar safety compared to a bare metal stent at five-year follow-up, according to data presented at the American Heart Association Scientific Session 2007.
November 04, 2007
News
November 5, 2007 - Pinyons Medical Technology announced it received FDA clearance to market the PowrSyringe Injector, a ...
November 04, 2007Technology
Pinyons Medical Technology offers the FDA-cleared PowrSyringe Injector, a disposable hand-held device designed to offer ergonomic and mechanical advantages to inject and aspirate fluids including use in angiography. The Injector’s crossing handles hinge to the syringe barrel and plunger to advance the plunger into the barrel when the handles are squeezed.
November 04, 2007Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024News
November 5, 2007 - According to late-breaking clinical trial results presented at the American Heart Association’s ...
November 04, 2007News
November 5, 2007 – Boston Scientific Corp. highlighted at the American Heart Association conference its new Stentplus ...
November 04, 2007News
November 4, 2007 – The antiplatelet drug prasugrel offered greater benefit than current, standard therapy for patients ...
November 03, 2007Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024News
November 4, 2007 – Drug-eluting stents to open blocked coronary arteries caused no more risks for death or heart attack than bare metal stents, according to a late-breaking outcomes trial presented at the American Heart Association’s Scientific Sessions 2007.
November 03, 2007News
November 4, 2007 - The prevalence of asymptomatic peripheral artery disease (PAD) is steadily increasing among American ...
November 03, 2007News
November 4, 2007 – Single photon emission computed tomography (SPECT) can identify which patients will benefit more from undergoing percutaneous coronary intervention (PCI) than receiving medical therapy alone for blocked coronary arteries, according to late-breaking clinical trial results presented at the American Heart Association’s Scientific Sessions 2007.
November 03, 2007Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023News
November 4, 2007 - A small, implantable device that helps the heart pump blood works equally well for men and women but ...
November 03, 2007News
November 4, 2007 – A specific way of dosing eptifibatide appears equally effective as giving abciximab as an adjunct to ...
November 03, 2007
Technology
Ovalum Ltd., a privately held Israeli medical device company, has received FDA marketing clearance for the CiTop ...
November 01, 2007Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023
Technology
ATS Medical Inc., manufacturer and marketer of state-of-the-art cardiac surgery products and services, received FDA ...
November 01, 2007Technology
Apollo Medical Imaging Technology’s MIStar multipurpose software reportedly combines a broad spectrum of advanced ...
October 31, 2007News
November 1, 2007 - TeraRecon, a provider of advanced visualization solutions, received the Frost & Sullivan 2007 Market ...
October 31, 2007© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now